Role of melatonin in the treatment of depression
https://doi.org/10.14412/2074-2711-2011-153
Abstract
Depression remains a serious problem despite the continuous stream of researches on the problems of affective disorders and the emergence of new antidepressants. About 80% of inpatients with depression and 70% of outpatients with this condition complain of sleep disorders. There are presently a few available hypotheses of the onset of depressive disorders. Prominent among them are neurotransmitter dysfunction hypotheses and chronobiological concepts (the presence of altered circadian rhythms mediated by melatonin). There is currently a wide range of drugs that are able to affect melatonin metabolism, amongst which there is agomelatine and fluvoxamine.
About the Author
O. V. Kotova
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Department of Autonomic Nervous System Pathology, Research Center
Moscow
References
1. <div><p>Лем Р. В. Расстройства сна и депрессия в аспекте действия антидепрессантов. Журн неврол и психиатр им. С.С. Корсакова 2008;108(12):75-8.</p><p>Амон М., Буае П.-Т., Моке Е. Перспективы в изучении патогенеза и терапии аффективных расстройств: роль мелатонина и серотонина. Журн неврол и психиатр им. С.С. Корсакова 2007;11:77-82.</p><p>Малин Д.И., Медведев В.М. Побочное действие антидепрессантов. Психиатр и психофармакотер 2002;5:190-3.</p><p>Мосолов С.Н. Диагностика и терапия депрессий в соматической практике. Психофармакотер депрессии 2006;7:1-12.</p><p>Смулевич А.Б. Депрессии при соматических и психических заболеваниях. М.: МИА, 2003;432 с.</p><p>Оганов Р.Г., Ольбинская Л.И., Смулевич А.Б. Депрессия и расстройства депрессивного спектра в общемедицинской практике. Результаты программы КОМПАС. Кардиология 2004;1:48-55.</p><p>Mendlewicz J. Sleep disturbances: core symptoms of major depressive disorder rather than associated or comorbid disorders. World J Biol Psychiat 2009;10(4):269-75.</p><p>Vaughn B.V., D'Cruz O.F., Beach R. et al. Improvement of epileptic seizure control with treatment of obstructive sleep apnoea. Seizure 1996;5(1):73-8.</p><p>Комаров Ф.И., Рапопорт С.И., Малиновская Н.К. и др. Мелатонин в норме и патологии. М: Медпрактика, 2004;308 с.</p><p>Arendt J.Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiology. Rev Reprod 1998;3(1):13-22.</p><p>Aton S.J., Colwell C.S., Harmar A.J. et al.Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. Nat Neurosci 2005;8(4):476-83.</p><p>Balzer I., Hardeland R.Melatonin in algae and higher-plants - possible new roles as a phytohormone and antioxidant. Botanica Acta 1996;109:180-3.</p><p>Wojtowicz M., Jakiel G. Melatonin and its role in human reproduction. Ginekol Pol 2002;73(12):1231-7.</p><p>Левин Я.И. Психические расстройства в общей медицине. Совр сомнол 2007;4:61-72.</p><p>Koenigsberg H.W., Teicher M.H., Mitropoulou V. et al. 24-h monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression. J Psychiat Res 2004;38:503-11.</p><p>Мосолов С.Н. Сравнительные полисомнографические характеристики больных биполярными фазно протекающими психозами с частыми («быстрые циклы») и редкими обострениями. Соц и клин психиатр 1992;3:20-9.</p><p>Mann J.J. The medical management of depression. N Engl J Med 2005;353:1819-34.</p><p>Rosenberg R.P. Sleep maintenance insomnia: strengths and weakness of current pharmacologic therapies. Ann Clin Psychiat 2006;18:49-56.</p><p>Wilson S., Argyropoulos S. Antidepressants and sleep: a qualitative review of the literature. Drugs 2005;65:927-47.</p><p>Bourin M., Mocaer E., Porsolt R. Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors. J Psychiatry Neurosci 2004;29:126-33.</p><p>Van Reeth O., Weibel L., Olivares E. et al. Melatonin or a melatonin agonist corrects agerelated changes in circadian response to environmental stimulus. Am J Physiol Regul Integr Comp Physiol 2001;280:R1582-91.</p><p>Demisch K., Demisch L., Bochnik H.J. et al. Melatonin and cortisol increase after fluvoxamine. Br J Clin Pharmacol 1986;22(5):620-2.</p><p>Demisch K. The influence of acute and subchronic administration of various antidepressants on early morning melatonin plasma levels in healthy subjects: increases following fluvoxamine. J Neural Transm 1987;68(3-4):257-70.</p><p>Skene D.J. Comparison of the effects of acute fluvoxamine and desipramine administration on melatonin and cortisol production in humans. Br J Clin Pharmacol 1994;37(2):181-6.</p><p>Hartter S., Wang H., Weigmann H. et al. Differential Effects of Fluvoxamine and Other Antidepressants on the Biotransformation of Melatonin. J Clin Psychopharmacol 2001;21(2):167-74.</p><p>Ha rtter S., Gro zinger M., Weigmann H. et al. Increased bioavailability of oral melatonin after fluvoxamine coadministration. Clin Pharmacol Ther 2000;67(1):1-6.</p><p>Иванов С.В. Эффекты флувоксамина и других антидепрессантов на метаболизм мелатонина. Психиатр и психофармакотер 2008;5:29-30.</p><p>Wilson S.J., Bell C., Coupland N.J. et al. Sleep changes during long-term treatment of depression with fluvoxamine - a home-based study. Psychopharmacology (Berl) 2000;149(4):360-5.</p><p>Neylan T.C., Metzler T.J., Schoenfeld F.B. et al. Fluvoxamine and sleep disturbances in posttraumatic stress disorder. J Trauma Stress 2001;14(3):461-7.</p><p>Westenberg H.G., Sandner C. Tolerability and safety of fluvoxamine and other antidepressants. Int J Clin Pract 2006;60(4):482-91.</p><p>Dalery J., Honig A. Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison. Hum Psychopharmacol 2003;18(5):379-84.</p><p>Котова О.В., Акарачкова Е.С. Тревожные депрессии с нарушениями сна в общемедицинской практике. Спр поликлин врача 2010;8:67-71.</p><p>Seretti A., Chiesa A. Treatment-Emerged Sexual Dysfunction Related to Antidepressants, A Meta-Analysis. J Clin Psychopharmacol 2009;9(3):259-66.</p><p>Jaquenoud E., Kat M. The safety of fluvoxamine in very elderly patients with depression and somatic symptoms. Prim Car Psychiatr 1997;3:175-81.</p><p>Buchberger R., Wagner W. Fluvoxamine: safety profile in extensive post-marketing surveillance. Pharmacopsychiatry 2002;35(3):101-8.</p><p>Инструкция по медицинскому применению препарата Вальдоксан.</p></div><br />
Review
For citations:
Kotova OV. Role of melatonin in the treatment of depression. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2011;3(2):85-88. (In Russ.) https://doi.org/10.14412/2074-2711-2011-153
Views:
1391
Email this article 